ReviewTranslational lung cancer research2017

Preclinical rationale for combining radiation therapy and immunotherapy beyond checkpoint inhibitors (i.e., CART).

James P Flynn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.